Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK investigates tampering with its alli weight-loss drug and positions itself as a consumer advocate with a U.S. recall of the product. By showing it is “on the side of good,” the firm could actually emerge from the crisis with a stronger reputation, crisis management expert Gene Grabowski says.

Advertisement

Related Content

Consumers Need Motivation To Buy Brands Returned To Stores After Absence
Omega Pharma Acquires Six Glaxo OTC Brands, But Alli Lingers
FDA Evaluates Alli For Potential Serious Risk Of Kidney Stones
Alli Campaign Seeks To "Drive Behavior Change," Stresses Healthy Choices
GSK's Quick Warning Of Fake Alli Exemplifies Effective Crisis Management
FDA Alerts Public To Ongoing Safety Review Of Orlistat In GSK, Roche Drugs

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS077109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel